Products & Services
Applications

Applications

Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
Resources
News Explore
Contact

The Oxford Nanopore executive team has combined experience in the development, manufacture and commercialisation of disruptive technologies including DNA sequencing. This includes a corporate function to support the Company's past and future fundraising activities.

Dr Gordon Sanghera - Chief Executive Officer
Dr Gordon Sanghera Chief Executive Officer
Dr Spike Willcocks - Vice President, Business and Corporate Development
Dr Spike Willcocks Chief BD Officer
Clive Brown - Chief Technology Officer
Clive Brown Chief Technology Officer
Dr John Milton - Chief Scientific Officer
Dr John Milton Chief Scientific Officer
John Schoellerman
John Schoellerman SVP, Corporate Development and Investment
Tim Cowper - VP, Finance
Tim Cowper VP, Finance
Zoe McDougall, VP, Marketing and Corporate Affairs
Zoe McDougall VP, Marketing and Corporate Affairs
Open a chat to talk to our sales team
FAQs

FAQs

Search